TISSARA Trial: Ticagrelor Intervention to Reduce Stent Thrombosis and Acute MI Risk

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1727 participants.

Also called NCT06667349

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 1,727 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06667349
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Pakistan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06667349. Non-randomized; no masking; primary purpose prevention. Start 2023-08-24 (actual); primary completion 2024-03-03 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
TISSARA Trial: Ticagrelor Intervention to Reduce Stent Thrombosis and Acute MI Risk
Acronym
TISSARA
Condition
STEMI - ST Elevation Myocardial Infarction
Condition
Stent Thrombosis
Condition
Antiplatelet Agents
Intervention (Drug)
Ticagrelor
Lead sponsor
National Institute of Cardiovascular Diseases, Pakistan (class: other)

Record details

Record id
cardio:ct-nct06667349
Content hash
8be4951632722381f904f2072a7fca64b13395eb8a7ca45bd2e777a1575a6c61